Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Additionally we are shipping NAGA Proteins (20) and NAGA Kits (15) and many more products for this protein.
Showing 10 out of 51 products:
Use of a modified Naga in the development of enzyme replacement therapy for Fabry disease is reported.
results demonstrate the utility of eQTL mapping in the identification of novel asthma genes and provide evidence for the importance of FADS2 (show FADS2 Antibodies), NAGA, and F13A1 (show F13A1 Antibodies) in the pathogenesis of asthma.
the active sites of human lysosomal enzymes alpha-galactosidase (show GLA Antibodies) and alpha-N-acetylgalactosaminidase have interconvertible specificites
Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation.
NAGA mutation p.D217N (c.649G>A) in exon 6 and mutation p.E325K (c.973G>A) in exon 8 may have roles in alpha-N-acetylgalactosaminidase deficiency with cardiomyopathy
Specific enzymatic activity of serum alpha-N-acetylgalactosaminidase was significantly increased in stage III melanoma patients, but not in early stages.
Use of a modified NAGA in the development of enzyme replacement therapy for Fabry disease is reported.
NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease).
, alpha-galactosidase B
, Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B)